NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| KRW | KRW/USD | null | null | 8.57% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 6.62% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 5.89% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.71% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 5.02% |
| 6160 | Beigene Ltd | Healthcare | Biotechnology | 5.01% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.70% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.69% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 4.62% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.27% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 4.13% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 3.76% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 3.76% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.64% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.11% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.94% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.71% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.31% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 2.28% |